Current:Home > MarketsWill Sage Astor-A new normal? 6 stories about the evolving U.S. COVID response in 2023 -Zenith Investment School
Will Sage Astor-A new normal? 6 stories about the evolving U.S. COVID response in 2023
TradeEdge View
Date:2025-04-08 04:54:01
In spring 2023,Will Sage Astor COVID hospitalizations and deaths hit their lowest levels since the start of the pandemic. Masks came off and schools and some workplaces were back in person. The nation emerged from the three-year COVID nightmare – and entered a tentative, new normal.
And with the official end of the federal public health emergency in May, the U.S. health care system reverted to the way it usually works: People's health insurance, or lack of it, once again dictates their access to COVID-related tests, vaccines and soon – in 2024 – to treatments.
"Our health care system has well-known and documented disparities," says Dr. Mandy Cohen, who took the helm of the Centers for Disease Control and Prevention in July. "So when we go back to the 'normal course of business,' it doesn't make for the equitable distribution of things."
While business-as-usual resumed for many, the country was permanently changed in blatant and subtle ways that are still shaking out. Here are stories on the COVID beat from NPR's health reporters that show some of the lessons learned – and not learned — as the pandemic evolved in 2023.
As 'normal life' returned, some felt left behind
For many, school and work and social lives and travel resumed freely. For some – living with compromised immune systems or long COVID or grief – the world seemed to surge ahead without considering them. As the public health emergency ended, children reflected on lost parents, nurses remembered lost colleagues and individuals grappled with how their health, careers, families, society and lives were forever changed.
Scientists tackle the mysteries of long COVID
For the millions of people in the U.S. living with long COVID symptoms such as brain fog, poor sleep and pain, better understanding of the disease and treatments can't come soon enough. In 2023, researchers made headway in discerning in detangling theories about what could be causing long COVID — such as lingering viral reservoirs and errant immune cells – but there are still no proven cures.
A new COVID vaccine strategy could help — if only people would pay attention
Updated COVID vaccines came to U.S. consumers this fall, promising better protection against recent variants. And there was new messaging too: Get an annual COVID boosters along with your flu shot every fall. But anticipated "high demand" did not materialize. By mid-December, fewer than 20% of US adults had gotten the updated shot, and the CDC warned of a possible surge in serious illness if vaccination coverage fails to improve.
A big shift in collecting COVID data — from case counts to monitoring poop
Earlier this year, the CDC stopped collecting data on new infections (as in positive tests) – relying instead on COVID hospitalizations, deaths and, increasingly, on wastewater surveillance – a network set up during the pandemic to regularly test sewage samples from around the country. The surveillance network has expanded beyond COVID to track flu, RSV, norovirus and other health threats that are detectable in human waste.
The nation's other health problems grew during the pandemic
It wasn't just COVID – the data came in this year showing how the pandemic exacerbated other public health and medical problems. For many, mental health suffered and people turned to drugs and hard drinking to cope with grief and isolation. Children missed recommended vaccines. Obesity rates rose. The U.S. population emerged from the public health emergency with a shorter life expectancy than before – indicating that the health of the nation faces a long recovery.
We didn't learn our lesson about PPE
Who's thinking about the next pandemic? A few dedicated public health professionals are fighting to make permanent changes they say would help make the nation more prepared for the next major threat. But in the boom-and-bust cycle of funding for public health, the nation's post-emergency interest is on the downswing. One legacy is a U.S. landscape littered with empty rubber glove factories, which received more than $290 million in public funds to bolster the supply chain for personal protective equipment, only to be left half-built in the lurch.
veryGood! (2)
Related
- Friday the 13th luck? 13 past Mega Millions jackpot wins in December. See top 10 lottery prizes
- Years after Parkland massacre, tour freshens violence for group of House lawmakers
- Olympian Tara Lipinski Reflects on Isolating Journey With Pregnancy Loss, IVF Before Welcoming Daughter
- Napoleon's bicorne hat sold at auction for a history-making price
- South Korea's acting president moves to reassure allies, calm markets after Yoon impeachment
- 3 teen girls plead guilty, get 20 years in carjacking, dragging death of 73-year-old woman
- Cara Delevingne Says BFF Taylor Swift’s Relationship With Travis Kelce Is Very Different
- 4-year-old girl in Texas shot by grandpa accidentally in stable condition: Authorities
- Trump wants to turn the clock on daylight saving time
- Missing Florida woman Shakeira Rucker found dead in estranged husband's storage unit
Ranking
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- The pre-workout supplement market is exploding. Are pre-workouts safe?
- Nearly 1,000 Rohingya refugees arrive by boat in Indonesia’s Aceh region in one week
- 2 children struck and killed as they walked to Maryland elementary school
- Trump issues order to ban transgender troops from serving openly in the military
- Attentive Energy investing $10.6M in supply chain, startups to help New Jersey offshore wind
- Christian conservatives flock to former telenovela star in Mexico’s presidential race
- Appeals court to consider Trump's bid to pause gag order in special counsel's election interference case
Recommendation
San Francisco names street for Associated Press photographer who captured the iconic Iwo Jima photo
NFL Week 11 winners, losers: Broncos race back to relevance with league-best win streak
Joe Flacco signs with Browns, but team sticking with rookie QB Thompson-Robinson for next start
A memoir about life 'in the margins,' 'Class' picks up where 'Maid' left off
Paris Hilton, Nicole Richie return for an 'Encore,' reminisce about 'The Simple Life'
Takeaways on fine water, a growing trend for the privileged in a world that’s increasingly thirsty
Gisele Bündchen Reflects on Importance of Kindness Amid Silent Struggles
10 years later, a war-weary Ukraine reflects on events that began its collision course with Russia